Article
The significance of TP53 in lymphoid malignancies: mutation prevalence, regulation, prognostic impact and potential as a therapeutic target.
British journal of haematology - 1 Aug 2009
Cheung K-John J, Horsman Douglas E, Gascoyne Randy D
Abstract excerpt
The tumour suppressor TP53 (previously termed p53) mediates a pathway that is considered to be one of the most important mechanisms in the maintenance of genomic stability. The function of TP53 can be abrogated by genomic deletion, mutation, or deregulation of upstream and downstream participants in the TP53 pathway. While aberrations of TP53 are widely prevalent in non-haematological malignancies (over 60%),...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
